Astellas Pharma Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
ALPMY Over the counter 2834 www.astellas.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Astellas Pharma Inc.

Mitsubishi Research Institute and Astellas Announce Collaboration to Support Pharma Startups in Japan - Jun 12th, 2025 11:10 pm
Are Medical Stocks Lagging Astellas Pharma (ALPMY) This Year? - Jun 12th, 2025 7:40 am
How leading oncology drugmakers set the stage for future advances - Jun 3rd, 2025 2:00 am
Astellas and Evopoint sign ADC licensing deal - May 30th, 2025 4:53 am
Keros lays off nearly half its staff; Astellas buys into a China biotech’s ADC - May 30th, 2025 4:36 am
Astellas Enters Exclusive License Agreement with Evopoint Biosciences for XNW27011, a Novel Clinical-stage Antibody-Drug Conjugate Targeting CLDN18.2 - May 29th, 2025 6:15 pm
Astellas Announces Second Annual Patient Advocacy Organization (PAO) Action Week™ To Empower Patients and Caregivers - May 28th, 2025 8:00 am
Is Astellas Pharma (ALPMY) Stock Outpacing Its Medical Peers This Year? - May 27th, 2025 7:40 am
Astellas and Pfizer’s Xtandi combo reduces death risk in prostate cancer trial - May 23rd, 2025 3:31 am
Astellas and Pfizer's XTANDI™ (enzalutamide) Shows Long-Term Overall Survival in Metastatic Hormone-Sensitive Prostate Cancer - May 22nd, 2025 3:00 pm
Astellas and MBC BioLabs Announce the 2025 Astellas Future Innovator Prize Awarded to DeepSeq.AI & Serna Bio - May 21st, 2025 9:00 am
Astellas Presents New Data that Explores Potential of its Cancer Therapies at 2025 ASCO Annual Meeting - May 19th, 2025 6:00 am
Here's Why Astellas Pharma (ALPMY) Is a Great 'Buy the Bottom' Stock Now - May 13th, 2025 7:55 am
Notice of Nominees for Directors - May 7th, 2025 4:00 am
Astellas to Present New Data in Geographic Atrophy at Upcoming Ophthalmology Annual Congresses - May 1st, 2025 7:00 am
Astellas Pharma (ALPMY) Upgraded to Strong Buy: What Does It Mean for the Stock? - Apr 29th, 2025 10:00 am
Is Astellas Pharma (ALPMY) Outperforming Other Medical Stocks This Year? - Apr 28th, 2025 7:40 am
Astellas Pharma and JFCR partner for oncology research - Apr 3rd, 2025 3:12 am
Astellas and Yaskawa form JV for cell therapy product manufacture - Mar 7th, 2025 3:34 am
Astellas and YASKAWA Agree to Establish a Joint Venture Focused on Cell Therapy Manufacturing - Mar 5th, 2025 9:02 pm